Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-07

FDA Approved: ZURNAI — Original Application (Purdue Pharma L.P.)

View source ↗

Summary

FDA approved ZURNAI (nalmefene hydrochloride) via an original NDA from Purdue Pharma L.P. for the treatment of alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZURNAI (Nalmefene hydrochloride)

Snippet

ORIG AP for ZURNAI (NALMEFENE HYDROCHLORIDE)